NewGen Implements Reverse Stock Split “`

February 1, 2025 by No Comments

NewGen’s shares will trade on a split-adjusted basis starting February 11, 2025.

BANGKOK, Jan. 31, 2025 — NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a leading Asian fertility services provider, announced a reverse stock split of all its issued and unissued shares, including Class A, Class B ordinary shares, and preferred shares. The split ratio is 1 new share for every 20 existing shares. This decision, approved by the Board of Directors on January 21, 2025, will take effect on February 11, 2025.

Class A Ordinary Shares will trade on the Nasdaq Global Market under the symbol “NIVF” with the new CUSIP number G0544E204.

The reverse split reduces outstanding Class A Ordinary Shares from roughly 27.07 million to approximately 1.35 million. Shareholders will receive one post-split share for every twenty shares held; fractional shares will be consolidated into whole shares.

Outstanding options, warrants, and convertible securities will be adjusted accordingly, dividing the number of exercisable or convertible shares by 20, subject to rounding.

This reverse stock split aims to help NewGen meet Nasdaq’s minimum $1.00 per share bid price requirement (Nasdaq Listing Rule 5450(a)(1)). Nasdaq granted an extension until April 7, 2025, but compliance is not guaranteed.

Continental Stock Transfer & Trust Company will handle the reverse stock split.

About NewGen

NewGen offers comprehensive fertility services across Asia, assisting couples and individuals in building families. The company strives to improve access to infertility treatments. Its clinics in Thailand, Cambodia, and Kyrgyzstan provide services including infertility treatments, egg and sperm donation, and surrogacy (where legally permissible). For more details, visit [website address]. Information on NewGen’s website is not part of this press release.

Forward-Looking Statements

This release includes forward-looking statements under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties. Actual results may differ materially due to factors including, but not limited to, the inability to implement business plans, identify opportunities, meet financial projections, or changes in the regulatory or competitive landscape. Refer to NewGen’s Form 20-F filing and other SEC documents for more details on risk factors. Information is current as of today’s date; no obligation exists to update forward-looking statements.

Investor Relations Contact

ICR, LLC
Robin Yang
Phone: +1 (212) 537-4406
Email: 

“`